Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome

Anna Szpakowicz1, Malgorzata Szpakowicz2, Magda Lapinska2

  • 1Department of Cardiology, Medical University of Bialystok, ul.Jana Kilinskiego 1, 15-089 Białystok, Poland.

Biomolecules
|August 27, 2021
PubMed

Insights

Chemerin levels in coronary artery disease (CAD) patients correlate with inflammation and insulin resistance. Its link to fat mass varies with glucose metabolism, suggesting different regulation mechanisms.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Chemerin, an adipokine and chemoattractant, is elevated in coronary artery disease (CAD).
  • Understanding chemerin's associations with metabolic and body composition markers is crucial in CAD patients.

Purpose of the Study:

  • To investigate the associations between serum chemerin levels and biochemical measurements.
  • To explore the relationship between chemerin and body composition in patients with stable CAD.

Main Methods:

  • Study included 163 patients with stable CAD post-percutaneous coronary intervention (PCI).
  • Serum chemerin, insulin, and c-peptide levels were measured.
  • Body composition was assessed using DEXA; biochemical markers were analyzed.

Main Results:

  • Chemerin positively correlated with white blood cell count, neutrophil-to-lymphocyte ratio, hsCRP, lipid profiles, triglycerides, platelets, fasting insulin, and c-peptide.
  • No significant difference in chemerin levels was found between diabetic and non-diabetic patients.
  • Chemerin correlated with total fat mass only in patients with normal glucose metabolism.

Conclusions:

  • Serum chemerin levels in CAD patients are linked to inflammation, insulin resistance, and dyslipidemia.
  • The association between chemerin and fat mass is contingent on glucose metabolism status.
  • Chemerin secretion regulation may differ based on diabetes or prediabetes presence.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
267
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
48
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
124
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
521
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
89
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
149